HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haoliang Xue Selected Research

alpha-1,3-mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase I

1/2022LINC00173 promotes Wilms' tumor progression through MGAT1-mediated MUC3A N-glycosylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Haoliang Xue Research Topics

Disease

4Neoplasms (Cancer)
03/2022 - 10/2017
1Renal Cell Carcinoma (Grawitz Tumor)
10/2017
1Uterine Neoplasms (Uterine Cancer)
10/2017
1Adenocarcinoma
10/2017

Drug/Important Bio-Agent (IBA)

2RNA (Ribonucleic Acid)IBA
03/2022 - 04/2021
1Long Noncoding RNAIBA
03/2022
1Biomarkers (Surrogate Marker)IBA
03/2022
1Polysaccharides (Glycans)IBA
01/2022
1alpha-1,3-mannosyl-glycoprotein beta-1,2-N-acetylglucosaminyltransferase IIBA
01/2022
1lenvatinibIBA
10/2017

Therapy/Procedure

1Therapeutics
10/2017
1Immunotherapy
10/2017